From video
Interpreted Prediction
Biotech companies are ending their destocking phase, and product orders are beginning to increase, as indicated by West Pharmaceutical and Wall Street analysts in late 2025.
AI Evaluation Notes
The prediction stated that biotech destocking would end and product orders would increase by late 2025, according to West Pharmaceutical and Wall Street analysts. While it's difficult to quantify the exact increase in product orders, reports suggest a general recovery in the biotech sector, making the prediction somewhat accurate.